Short interest in Paradigm Biopharmaceuticals Ltd (OTC:PBIGF) increased during the last reporting period, rising from 198.35K to 213.34K. This put -% of the company's publicly available shares short.
NEW YORK CITY, NY / ACCESS Newswire / February 10, 2026 / Against the backdrop of the ongoing deepening of the global digital economy, the short-video industry is evolving from its early phase of ...
NEW YORK, NY, UNITED STATES, February 10, 2026 /EINPresswire.com/ — Against the backdrop of the ongoing deepening of the global digital economy, the short-video ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results